How do amphetamines affect dopamine

Age-dependent differential responses of monoaminergic systems to high doses of methamphetamine. J Neurochem ; 75 : — Tolerance to the neurotoxic effects of methamphetamine in young rats.

Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled year follow-up study. Abuse of amphetamines and structural abnormalities in brain.

In: Uhl G ed. Addiction Reviews , vol. Jaffe JH. Drug addiction and drug abuse. Pharmacological Basis of Therapeutics. McMillan: New York, , pp — In vivo evidence that methamphetamine abuse produces long lasting changes in dopamine transporters in human brain. J Nucl Med Suppl ; 40 Suppl : J Neurosci ; 18 : — A comparison of patterns of methamphetamine and cocaine use.

J Addict Dis ; 21 : 35— Article PubMed Google Scholar. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med ; 2 : — Psychiatric comorbidity of methamphetamine dependence in a forensic sample. J Neuropsychiatry Clin Neurosci ; 12 : — Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling. Synapse ; 61 : — Structural and metabolic brain changes in the striatum associated with methamphetamine abuse.

Addiction ; Suppl 1 : 16— Why is parkinsonism not a feature of human methamphetamine users? Brain ; : — Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J Neurosci ; 19 : — Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss.

J Neurochem ; 74 : — Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters. Nucl Med Biol ; 23 : — Dopamine transporters and neuronal injury. Trends Pharmacol Sci ; 20 : — The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.

Arch Gen Psychiatry ; 61 : 73— Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse. Mol Psychiatry ; e-pub: 16 October Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Structural abnormalities in the brains of human subjects who use methamphetamine.

J Neurosci ; 24 : — Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Effects of methamphetamine dependence and HIV infection on cerebral morphology. Evidence for long-term neurotoxicity associated with methamphetamine abuse: a 1H MRS study.

Neurology ; 54 : — Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry ; 62 : — Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Metabolite alterations in basal ganglia associated with methamphetamine-related psychiatric symptoms: a proton MRS study. Neuropsychopharmacology ; 27 : — Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms.

Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry ; 63 : 90— Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in orbitofrontal cortex. Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers.

Biol Psychiatry ; 58 : — Decreased cerebral blood flow of the right anterior cingulate cortex in long-term and short-term abstinent methamphetamine users. Drug Alcohol Depend ; 82 : — Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

J Neurosci ; 21 : — The nature, time course and severity of methamphetamine withdrawal. Methamphetamine abstinence syndrome: preliminary findings. Am J Addict ; 13 : — Brain injury: prolonged induction of transcription factors. Acta Neurobiol Exp Wars ; 60 : — CAS Google Scholar. Decision making, the P3, and the locus coeruleus-norepinephrine system. Psychol Bull ; : — Polich J, Criado JR. Neuropsychology and neuropharmacology of P3a and P3b. Int J Psychophysiol ; 60 : — Effects of repeated administration of methamphetamine on P3-like potentials in rats.

Int J Psychophysiol ; 32 : — Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am J Psychiatry ; : 75— Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse ; 14 : — Unterharnscheidt F. A neurologist's reflections on boxing. Conclude remarks.

Rev Neurol ; 23 : — Relationship among neuroimaging indices of cerebral health during normal aging. Hum Brain Mapp ; 29 : 36— Arch Gen Psychiatry ; 56 : — Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine.

J Neurochem ; 68 : — Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine. Synapse ; 59 : — Human response to repeated low-dose D -amphetamine: evidence for behavioral enhancement and tolerance. Becker JB. Gender differences in dopaminergic function in striatum and nucleus accumbens.

Pharmacol Biochem Behav ; 64 : — Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Angrist B, Gershon S. Dopamine and psychotic states: preliminary remarks. Adv Biochem Psychopharmacol ; 12 : — Stimulant psychosis: systematic review. Br J Psychiatry ; : — Griffith J. A study of illicit amphetamine drug traffic in Oklahoma city.

The prevalence of psychotic symptoms among methamphetamine users. Psychiatr Prax ; 32 : 13— Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia.

Ann NY Acad Sci ; : 1— Factors for susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis. Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis.

Pharmacogenomics J ; 3 : — Ujike H. Nihon Shinkei Seishin Yakurigaku Zasshi ; 24 : — Amphetamine-induced movement disorder.

Emerg Med Australas ; 17 : — Amphetamine metabolism in amphetamine psychosis. Clin Pharmacol Ther ; 14 : — Epoxidation of the methamphetamine pyrolysis product, trans -phenylpropene, to trans -phenylpropylene oxide by CYP enzymes and stereoselective glutathione adduct formation. Toxicol Appl Pharmacol ; : — Cherland E, Fitzpatrick R.

Psychotic side effects of psychostimulants: a 5-year review. Can J Psychiatry ; 44 : — Psychostimulants for secondary depression in medical illness. Psychosomatics ; 32 : — Murray JB. Psychophysiological aspects of amphetamine—methamphetamine abuse. J Psychol ; : — Pemoline abuse. Adderall-induced psychosis in an adolescent. J Am Board Fam Pract ; 15 : — Ross RG. Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder.

Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: a case—control study. Sleep ; 28 : — Psychiatric morbidity in narcoleptics on chronic high dose methylphenidate therapy.

J Nerv Ment Dis ; : 45— Am J Med Genet ; 67 : — Drug Alcohol Depend ; 52 : — An association study between catechol- O -methyl transferase gene polymorphism and methamphetamine psychotic disorder.

Psychiatr Genet ; 16 : — Identification of functional polymorphisms in the promoter region of the human PICK1 gene and their association with methamphetamine psychosis. Madras BK. Imaging the dopamine transporter: a window on dopamine neurons. In: Marwab J, Teitelbaum H ed. Advances in Neurodegenerative Disorders , vol. Synapse ; 45 : 52— Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients.

World J Biol Psychiatry ; 5 : 38— Nomifensine attenuates D -amphetamine-induced dopamine terminal neurotoxicity in the striatum of rats. Chin J Physiol ; 43 : 69— Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors. Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q Neurochem Res ; 31 : — Baicalein attenuates methamphetamine-induced loss of dopamine transporter in mouse striatum. Toxicology ; : — J Pineal Res ; 43 : 65— Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N -acetylcysteine but not D1 and D2 dopamine receptor agonists.

Iversen LL. Speed, Ecstasy, Ritalin: the Science of Amphetamines. Combining structural and functional neuroimaging data for studying brain connectivity: a review. Psychophysiology ; 45 : — Brain mapping as a tool to study neurodegeneration. Neurotherapeutics ; 4 : — Voxel-based cortical thickness measurements in MRI. Neuroimage ; 40 : — A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users.

Download references. You can also search for this author in PubMed Google Scholar. Correspondence to E D London.

Reprints and Permissions. Berman, S. Potential adverse effects of amphetamine treatment on brain and behavior: a review. The research shows that the technology works on both In the study, researchers show that this heightened sensitivity to loss ScienceDaily shares links with sites in the TrendMD network and earns revenue from third-party advertisers, where indicated.

Print Email Share. Boy or Girl? Just a Game? Living Well. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. U S A 96, — Davern, P. A role for the lateral PB nucleus in cardiovascular function and fluid homeostasis. DeBoer, P. Physiological release of striatal acetylcholine in vivo : modulation by D1 and D2 dopamine receptor subtype. Nicotinic and muscarinic cholinergic receptors are recruited by acetylcholine-mediated neurotransmission within the locus coeruleus during the organisation of post-ictal antinociception.

Delle Donne, K. Protection against methamphetamine-induced neurotoxicity to neostriatal dopaminergic neurons by adenosine receptor activation. Deutch, A. Activation of the locus coeruleus induced by selective stimulation of the ventral tegmental area. Devoto, P.

Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex. Di Chiara, G. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

U S A 85, — Dickinson, S. Psychopharmacology 96, — Dobbs, L. The role of the laterodorsal tegmental nucleus in methamphetamine conditioned place preference and locomotor activity.

Comparison of systemic and local methamphetamine treatment on acetylcholine and dopamine levels in the ventral tegmental area in the mouse.

Acetylcholine from the mesopontine tegmental nuclei differentially affects methamphetamine induced locomotor activity and neurotransmitter levels in the mesolimbic pathway. Dougalis, A. Functional properties of dopamine neurons and co-expression of vasoactive intestinal polypeptide in the dorsal raphe nucleus and ventro-lateral periaqueductal grey.

Dresse, A. Importance of the noradrenergic mesencephalotelencephalic system as an anatomic substrate of autostimulation behavior. Life Sci. Drew, A. Nicotinic receptor-mediated regulation of dopamine transporter activity in rat prefrontal cortex. Synapse 38, 10— Drouin, C. Synapse 43, 51— Dun, S.

Cocaine- and amphetamine-regulated transcript peptide-immunoreactivity in adrenergic C1 neurons projecting to the intermediolateral cell column of the rat. Engelman, H. Presynaptic ionotropic receptors and control of transmitter release. Organization of noradrenergic efferents to arousal-related basal forebrain structures. Norepinephrine at the nexus of arousal, motivation and relapse.

Estabrooke, I. Fos expression in orexin neurons varies with behavioral state. Ferrucci, M. Pathways of methamphetamine toxicity. Fibiger, H. Role of dopamine and norepinephrine in the chemistry of reward. Fleckenstein, A. New insights into the mechanism of action of amphetamines. Fornai, F. Noradrenergic modulation of methamphetamine-induced striatal dopamine depletion. Noradrenaline loss selectivity exacerbates nigrostriatal toxicity in different species of rodents.

Region-and neurotransmitter-dependent species and strain differences in DSPinduced monoamine depletion in rodents. Neurodegeneration 5, — Norepinephrine loss selectively enhances chronic nigrostriatal dopamine depletion in mice and rats.

Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice. Dose-dependent protective effects of apomorphine against methamphetamine-induced nigrostriatal damage. Effects of pretreatment with N- 2-chloroethyl -N-ethylbromobenzylamine DSP-4 on methamphetamine pharmacokinetics and striatal dopamine losses.

Similarities between methamphetamine toxicity and proteasome inhibition. Forster, G. Effects of laterodorsal tegmentum excitotoxic lesions on behavioral and dopamine responses evoked by morphine and d-amphetamine.

Fulceri, F. Abnormal involuntary movements AIMs following pulsatile dopaminergic stimulation: severe deterioration and morphological correlates following the loss of locus coeruleus neurons. Gesi, M. Novel aspects of dopamine oxidative metabolism confounding outcomes take place of certainties. Godino, A. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents. Epigenetics 10, — Gompf, H. Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity.

Grenhoff, J. Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. Neural Transm. Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Gresch, P. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex.

Guyenet, P. Central noradrenergic neurons: the autonomic connection. The sympathetic control of blood pressure. Rostral ventrolateral medulla and sympathorespiratory integration in rats.

Hagan, J. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Hajnal, A. Parabrachial coding of sapid sucrose: relevance to reward and obesity.

Electrical stimulation of the dorsal and median raphe nuclei increases extracellular noradrenaline in rat hippocampus: evidence for a 5-HT-independent mechanism. Hanson, L.

Evidence that the central action of amphetamine is mediated via catecholamines. Psychopharmacologia 9, 78— Harro, J. Lesioning of locus coeruleus projections by DSP-4 neurotoxin treatment: effect on amphetamine-induced hyperlocomotion and dopamine D2 receptor binding in rats.

Hayward, L. Respiratory response to activation or disinhibition of the dorsal periaqueductal gray in rats. Heal, D. Amphetamine, past and present—a pharmacological and clinical perspective. Immunochemical evidence for the existence of adrenaline neurons in the rat brain. Homer, B. Methamphetamine abuse and impairment of social functioning: a review of the underlying neurophysiological causes and behavioral implications.

Hondebrink, L. Neurotoxicology 33, — Hong, W. Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine- or PKC-regulated endocytosis in dopamine neurons. Howe, P. Simultaneous demonstration of phenylethanolamine N-methyltransferase immunofluorescent and catecholamine fluorescent nerve cell bodies in the rat medulla oblongata. Neuroscience 5, — Imperato, A.

Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus. Inglis, W. An investigation into the role of the pedunculopontine tegmental nucleus in the mediation of locomotion and orofacial stereotypy induced by d-amphetamine in the rat.

Neuroscience 58, — Iversen, L. The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart. Jayanthi, S. Juhila, J. Kalayasiri, R. Addiction , — Keys, A. D1 and D2 dopamine receptor mediation of amphetamine-induced acetylcholine release in nucleus accumbens. Neuroscience 86, — Kikuchi-Utsumi, K. Kim, M. Reciprocal connections between subdivisions of the dorsal raphe and the nuclear core of the locus coeruleus in the rat.

Kirouac, G. Cardiovascular afferent inputs to ventral tegmental area. Kish, S. Brain choline acetyltransferase activity in chronic, human users of cocaine, methamphetamine, and heroin. Psychiatry 4, 26— Krivanek, J. Protein kinase C in the parabrachial nucleus of rats during conditioned taste aversion induced by amphetamine.

Lategan, A. Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP a microdialysis study. Lester, D. Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci. Li, Y. Collateral projections from the midbrain periaqueductal gray to the nucleus raphe magnus and nucleus accumbens in the rat.

A fluorescent retrograde double-labelling study. Li, C. Neuropsychopharmacology 41, — Li, A. Hindbrain catecholamine neurons activate orexin neurons during systemic glucoprivation in male rats. Endocrinology , — Li, F. Bioenergetics failure and oxidative stress in brain stem mediates cardiovascular collapse associated with fatal methamphetamine intoxication. PLoS One 7:e Limanaqi, F. Epigenetic effects induced by methamphetamine and methamphetamine-dependent oxidative stress.

Lin, M. Methamphetamine-induced neurotoxicity linked to ubiquitin-proteasome system dysfunction and autophagy-related changes that can be modulated by protein kinase C delta in dopaminergic neuronal cells.

Lin, L. Chronic cognitive deficits and amyloid precursor protein elevation after selective immunotoxin lesions of the basal forebrain cholinergic system. Neuroreport 9, — Liprando, L. Ultrastructural interactions between terminals expressing the norepinephrine transporter and dopamine neurons in the rat and monkey ventral tegmental area.

Synapse 52, — Liu, W. Loughlin, S. Locus coeruleus projections to cortex: topography, morphology and collateralization. Lovick, T. Integrated activity of cardiovascular and pain regulatory systems: role in adaptive behavioural responses. Lu, J. Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter. MacDermott, A. Presynaptic ionotropic receptors and the control of transmitter release. Mahler, S. Multiple roles for orexin hypocretin in addiction. Mai, J.

The Human Nervous System. Atlas of The Human Brain. Mandel, R. Amphetamine induces excess release of striatal acetylcholine in vivo that is independent of nigrostriatal dopamine. Marchese, N. Angiotensin II AT 1 receptors mediate neuronal sensitization and sustained blood pressure response induced by a single injection of amphetamine.

Marcus, J. Differential expression of orexin receptors 1 and 2 in the rat brain. Marshall, J. Methamphetamine influences on brain and behavior: unsafe at any speed? Trends Neurosci. Martelli, D. The emerging role of the PB complex in the generation of wakefulness drive and its implication for respiratory control. Mavridis, M. Amphetamines are drugs such as dextroamphetamine and benzedrine. Amphetamines were originally developed to treat asthma, sleep disorders narcolepsy and hyperactivity.

In , a drug called "ephedrine" was used to treat asthma. In China, the ma huang plant Ephedra vulgaris had been used for centuries to treat people with asthma.